Omeros Corp reports results for the quarter ended September 30 - Earnings Summary

• Omeros Corp OMER.OQ reported quarterly adjusted earnings of 98 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -54 cents. The mean expectation of five analysts for the quarter was for a loss of 44 cents per share. Wall Street expected results to range from -52 cents to -30 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Omeros Corp's reported EPS for the quarter was a loss of 47 cents​.

• The company reported a quarterly loss of $30.92 million.

• Omeros Corp shares had fallen by 42.9% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Omeros Corp is $40.00, about 73.6% above its last closing price of $10.56

This summary was machine generated from LSEG data March 31 at 11:21 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)